| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.024 | 0.9 |